Cover Image

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

Luca Degli Esposti,1 Chiara Veronesi,1 Valentina Perrone,1 Stefano Buda,1 Antonio Santoro2 1Clicon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy; 2Department of Nephrology and Dialysis, Policlinico S. Orsola-Malpighi, Bologna, Italy Objective: The aim of this study was to assess h...

Full description

Saved in:

Bibliographic Details
Main Authors:	Degli Esposti L (Author), Veronesi C (Author), Perrone V (Author), Buda S (Author), Santoro A (Author)
Format:	Book
Published:	Dove Medical Press, 2017-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting
by: Perrone V, et al.
Published: (2016)

Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy
by: Perrone V, et al.
Published: (2021)

Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units
by: Perrone V, et al.
Published: (2017)

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy
by: Sangiorgi D, et al.
Published: (2017)

Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
by: L. Degli Esposti, et al.
Published: (2021)

Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy
by: Degli Esposti L, et al.
Published: (2022)

Analysis of Patients with Focal Epilepsy and Drug-Resistant Epilepsy in Italy: Evaluation of Their Characteristics, Therapeutic Pathway and the Consumption of Healthcare Resources
by: Perrone V, et al.
Published: (2022)

Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
by: Degli Esposti L, et al.
Published: (2014)

Implications of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: A Proposed Observational Investigation by the Fail-to-Refill Project
by: Degli Esposti L, et al.
Published: (2020)

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
by: Degli Esposti L, et al.
Published: (2013)

Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study
by: Degli Esposti L, et al.
Published: (2014)

Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study
by: Perrone V, et al.
Published: (2016)

Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study
by: Degli Esposti L, et al.
Published: (2012)

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy
by: Degli Esposti L, et al.
Published: (2016)

Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region
by: Perrone V, et al.
Published: (2020)

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
by: Degli Esposti L, et al.
Published: (2014)

Epidemiology, Patients' Journey and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Evidence Analysis in Italy
by: Diego Luigi Cortinovis, et al.
Published: (2023)

Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data
by: Knight T, et al.
Published: (2015)

Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis
by: Perrone V, et al.
Published: (2020)

Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital
by: Perrone V, et al.
Published: (2019)

Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease
by: Iyer NN, et al.
Published: (2018)

Real-world costs of autosomal dominant polycystic kidney disease in the Nordics
by: Daniel Eriksson, et al.
Published: (2017)

Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases
by: C. Veronesi, et al.
Published: (2012)

Polycystic Kidney Disease
Published: (2015)

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
by: Colombo GL, et al.
Published: (2021)

Clinical and economic burden of respiratory syncytial virus in children aged 0-5 years in Italy
by: Melania Dovizio, et al.
Published: (2024)

Pathways, perspectives and pursuits in polycystic kidney disease
by: Bhaskar L. V. K. S., et al.
Published: (2016)

Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of ostheoarthritis
by: P. Russo, et al.
Published: (2002)

Outpatient healthcare costs associated with overweight and obesity in Italy
by: Vincenzo Atella, et al.
Published: (2023)

AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE
by: Anja Fon Gabršček, et al.
Published: (2022)

Autosomal Recessive Polycystic Kidney Disease
by: Sajad Ahmad Salati
Published: (2014)

End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases
by: Brunelli SM, et al.
Published: (2015)

Novel Insights on Chronic Kidney Disease, Acute Kidney Injury and Polycystic Kidney Disease
Published: (2012)

Costs and healthcare utilisation of patients with chronic kidney disease in Spain
by: Carlos Escobar, et al.
Published: (2021)

Laparoscopic nephrectomy for polycystic kidney disease: Benefit or necessity?
by: Mikhail A. Firsov, et al.
Published: (2023)

Approximation to the Consumption of Healthcare Resources and the Economic Cost of SARS-CoV-2 Patient Management: A Retrospective Study
by: Jesús Calderón-Moreno, et al.
Published: (2022)

Nitric oxide synthase and polycystic kidney disease
by: Wiwanitkit Viroj
Published: (2015)

Peritoneal dialysis in polycystic kidney disease patients
by: Hajar Benzouina, et al.
Published: (2020)

Emerging Therapies for Childhood Polycystic Kidney Disease
by: William E. Sweeney, et al.
Published: (2017)

Autophagy and Autosomal Dominant Polycystic Kidney Disease
by: Özgür Akın Oto, et al.
Published: (2023)